BCAP31 and Parkinson disease: Our findings highlight BAP31 as a master coordinator of dopaminergic circuit integrity and a potential therapeutic target to enhance mitochondrial resilience in neurodegenerative disorders, offering new strategies to counteract proteostasis failure in PD and related proteinopathies.